Office of National Drug Control Policy Reauthorization Act of 2024

Where This Stands

Introduced

Committee

Floor Vote

Passed

Signed

Currently IN_COMMITTEE. The next step in the legislative lifecycle is Floor Vote.

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

The Frame

What this does

The bill sets federal priorities and funding levels for drug control and addiction treatment programs through 2031, directly impacting the resources available to state and local law enforcement and public health agencies for opioid overdose prevention and fentanyl interdiction.

Who is mentioned in the record

Potentially affected actors named in the source documents. Mention is not a position.

State and local law enforcement

These agencies will receive federal guidance and potential funding adjustments for drug trafficking enforcement and fentanyl interdiction.

Public health agencies

These entities are tasked with implementing new strategies for the distribution and education of opioid overdose reversal medications.

Assistant United States Attorneys

These individuals may be subject to temporary reassignment to prioritize the investigation and prosecution of fentanyl trafficking organizations.

What changed

Current stage: IN_COMMITTEE.

What's next

Floor Vote.

Summary

This bill reauthorizes the Office of National Drug Control Policy through 2031 and expands its mandate to include , fentanyl interdiction, and data-driven reporting on drug trafficking. It increases funding for various anti-drug programs and requires new strategies for addressing opioid overdoses and border-related drug threats.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Why It Matters

The bill sets federal priorities and funding levels for drug control and addiction treatment programs through 2031, directly impacting the resources available to state and local law enforcement and public health agencies for opioid overdose prevention and fentanyl interdiction.

Frequently Asked Questions

What is the primary goal of this bill?

The bill aims to reauthorize the Office of National Drug Control Policy and update its strategies to focus more heavily on fentanyl interdiction, , and the use of evidence-based data to combat drug trafficking.

Does this bill change how opioid reversal drugs like naloxone are handled?

Yes, it mandates that the Office of National Drug Control Policy prioritize the availability of opioid antagonists and requires a new federal strategy to ensure these medications are accessible to first responders and the public.

How does this bill affect law enforcement resources?

It provides specific funding for fentanyl interdiction and allows the Attorney General to temporarily reassign federal prosecutors to focus on fentanyl-related cases.

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Related Legislation

Federal Bill85% related

Supporting Youth Opportunity and Preventing Delinquency Act of 2016

This bill reauthorizes and updates the Juvenile Justice and Delinquency Prevention Act of 1974 to improve how states and tribes manage juvenile justic

Discoveries

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift90% confidence

Increased Focus on Fentanyl

The bill marks a significant shift toward prioritizing fentanyl-specific interdiction, including dedicated funding and prosecutorial resources.

Office of National Drug Control Policy Drug Enforcement Administration

Connected Entities

personNadler“Representative sponsoring the bill”Map →

personPlaskett“Representative sponsoring the bill”Map →

personGonzalez-Colon“Representative sponsoring the bill”Map →

organizationCommittee on Oversight and Accountability“Committee responsible for reviewing the bill”Map →

organizationCommittee on Energy and Commerce“Committee responsible for reviewing the bill”Map →

personComer“Representative introducing the bill”Map →

personDuarte“Representative sponsoring the bill”Map →

organizationCommittee on the Judiciary“Committee responsible for reviewing the bill”Map →

personRaskin“Representative sponsoring the bill”Map →

organizationOffice of National Drug Control Policy“The agency being reauthorized”Map →

organizationU.S. Government Publishing Office“Source of the document”Map →

Analysis Score

0–100

Significance85
How much this matters to a regular citizen
Controversy40
Intensity of disagreement among stakeholders
Entertainment10
Compellingness for a non-policy-wonk reader
Buzz30
Current news / social attention level